
Prezent Appoints Janet Dorling to Board to Advance AI in Biopharma
Prezent has appointed Janet Dorling to its Board of Directors, a move aimed at accelerating its AI initiatives in the biopharmaceutical industry, announced in a press release. Dorling, who has over 25 years of leadership experience, is currently a Senior Vice President at Gilead Sciences, a global biopharmaceutical company.
Dorling's expertise in the biotech and pharma sectors is expected to be instrumental as Prezent continues to develop its AI platform for business presentations. Her previous experience with Prezent's platform, including its AI agent Astrid, has shown significant improvements in communication efficiency and quality.
The appointment is part of Prezent's broader strategy to enhance organizational productivity by addressing communication challenges. The company recently raised $20 million in funding to expand its AI capabilities into new industries and geographies, further supporting its mission to streamline business communication.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Market report
Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential
This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.
Read more